Literature DB >> 17460499

Giant cell hepatitis and autoimmune hemolytic anemia successfully treated with rituximab.

Tamir Miloh1, Deepa Manwani, Raffaella Morotti, Emre Sukru, Benjamin Shneider, Nanda Kerkar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17460499     DOI： 10.1097/MPG.0b013e31802e9739

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  4 in total

1.  Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.

Authors:  Darla Shores; Gregory Kobak; Linda D Pegram; Peter F Whitington; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-10       Impact factor: 2.839

2.  Giant cell hepatitis with autoimmune hemolytic anemia in a nine month old infant.

Authors:  Jihene Bouguila; Sameh Mabrouk; Samia Tilouche; Dajla Bakir; Amel Trabelsi; Amel Hmila; Lamia Boughammoura
Journal:  World J Hepatol       Date:  2013-04-27

Review 3.  Autoimmune Hemolytic Anemia in the Pediatric Setting.

Authors:  Aikaterini Voulgaridou; Theodosia A Kalfa
Journal:  J Clin Med       Date:  2021-01-09       Impact factor: 4.241

4.  Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab.

Authors:  Young Ho Kim; Ju Whi Kim; Eun Joo Lee; Gyeong Hoon Kang; Hyoung Jin Kang; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.